The cellular metabolism mediated by mTOR is involved in the connections between cancer cells and tumor microenvironment during cancer advance and drug resistance acquisition, indicating the potential benefits of PI3K-Akt (protein kinase B)-mTOR pathway blockage. The gene discussed is AKT1; the disease is neoplasm.